Genoa Ventures

San Francisco, California
Genoa Ventures invests in early-stage life sciences technology companies. They fund entrepreneurs and companies looking to change the way science gets done with new tools and technologies. Sector focus areas include research tools, molecular diagnostics, synthetic biology, and industrial biology. Genoa Ventures was founded in 2014 by Jenny Rookeand is based in San Francisco, California, United States.
Founded:2014
Firm Location:San Francisco, California • Berkeley, California • Burlingame, California
Genoa Ventures Team
Photo of Vikram Chaudhery, Principal at Genoa Ventures
Vikram Chaudhery
Genoa Ventures·Principal
Sweet spot: $2.0M
Range: $250K - $10.0M
Investors in San Francisco (CA)
Photo of Paco Cifuentes, Venture Partner at Genoa Ventures
Paco Cifuentes
Genoa Ventures·Venture Partner
Sweet spot: $2.0M
Range: $250K - $10.0M
Investors in SF Bay Area (CA)
Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in San Francisco Bay Area (Other Lists), Investors in BioTech (Series A), Investors in Diagnostics (Seed), Investors in Diagnostics (Series A), Investors in Diagnostics (Seed), Investors in Diagnostics (Series A), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Series A), Investors in Digital Health (Seed)
Photo of Tony Day, Venture Partner at Genoa Ventures
Tony Day
Genoa Ventures·Venture Partner
Sweet spot: $2.0M
Range: $250K - $10.0M
Investors in SF Bay Area (CA), Investors in San Francisco (CA)
Investors in Impact (Seed), Investors in Food and Beverage (Seed), Investors in Food and Beverage (Series A), Investors in Impact (Series A), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Food and Beverage (Seed), Investors in Impact (Seed), Investors in San Francisco Bay Area (Other Lists), Investors in BioTech (Series A), Investors in Food and Beverage (Series A), Investors in Impact (Series A)
Photo of Bill Hyun, Venture Partner at Genoa Ventures
Bill Hyun
Genoa Ventures·Venture Partner
Sweet spot: $2.0M
Range: $250K - $10.0M
Investors in SF Bay Area (CA)
Investors in Medical Devices (Seed), Investors in Robotics (Seed), Investors in Consumer Health (Series A), Investors in Web3/Blockchain (Seed), Investors in Medical Devices (Series A), Investors in Robotics (Series A), Investors in BioTech (Seed), Investors in Web3/Blockchain (Series A), Investors in Diverse Investors (Other Lists), Investors in Consumer Health (Seed), Investors in Investors who invested in female founders (Other Lists), Investors in Investors who were founders (Other Lists), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in Investors who invested in diverse founders (Other Lists), Investors in Web3/Blockchain (Seed), Investors in Consumer Health (Seed), Investors in BioTech (Seed), Investors in Health IT (Seed), Investors in Health & Hospital Services (Series A), Investors in Medical Devices (Seed), Investors in San Francisco Bay Area (Other Lists), Investors in Health & Hospital Services (Seed), Investors in Robotics (Seed), Investors in BioTech (Series A), Investors in Web3/Blockchain (Series A), Investors in Consumer Health (Series A), Investors in Health IT (Series A), Investors in Medical Devices (Series A), Investors in Robotics (Series A), Investors in Health & Hospital Services (Series A), Investors in Angel, Scout, and Solo-Capitalists (Other Lists), Investors in Drug Delivery (Series A), Investors in Diagnostics (Seed), Investors in Diagnostics (Series A), Investors in Drug Delivery (Series A), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Seed), Investors in Diagnostics (Seed), Investors in Diagnostics (Series A), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Medical Devices (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Robotics (Pre-seed), Investors in Web3/Blockchain (Pre-seed), Investors in Health IT (Pre-seed), Investors in Digital Health (Pre-seed), Investors in BioTech (Pre-seed), Investors in Consumer Health (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Web3/Blockchain (Pre-seed), Investors in Health IT (Pre-seed), Investors in Consumer Health (Pre-seed), Investors in Robotics (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in BioTech (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in Digital Health (Pre-seed), Investors in Health IT (Seed), Investors in Health & Hospital Services (Pre-seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
Photo of Richard Kenny, Venture Partner at Genoa Ventures
Richard Kenny
Genoa Ventures·Venture Partner
Sweet spot: $2.0M
Range: $250K - $10.0M
Investors in SF Bay Area (CA), Investors in San Francisco (CA)
Photo of Negin Mokhtari, Senior Associate at Genoa Ventures
Negin Mokhtari
Genoa Ventures·Senior Associate
Sweet spot: $2.0M
Range: $250K - $10.0M
Investors in San Francisco (CA)
Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in San Francisco Bay Area (Other Lists), Investors in BioTech (Series A)
Photo of Jenny Rooke, Managing Director at Genoa Ventures
Jenny Rooke
Genoa Ventures·Managing Director
Sweet spot: $2.0M
Range: $250K - $10.0M
Investors in San Francisco (CA)
Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series B), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Seed), Investors in San Francisco Bay Area (Other Lists), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series B), Investors in Pharmaceuticals (Series B), Investors in Diagnostics (Seed), Investors in Diagnostics (Series B), Investors in Diagnostics (Series A), Investors in Diagnostics (Series B), Investors in Diagnostics (Seed), Investors in Diagnostics (Series A)
Photo of David Summa, Venture Partner at Genoa Ventures
David Summa
Genoa Ventures·Venture Partner
Sweet spot: $2.0M
Range: $250K - $10.0M
Investors in SF Bay Area (CA)
Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in San Francisco Bay Area (Other Lists), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A)